← Eichor
Study identifier: NCT06712420 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Condition: Gall Bladder Carcinoma  ·  Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India

PhasePhase 3
Planned participants114
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly

This description comes directly from the study's public registry record.

Talk to the study team

Shivendra Singh, Mch  ·  +919818975024  ·  shiven_24@yahoo.co.in

Shaifali Goel, DrNB  ·  +918368382060  ·  doctor.shaifali@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Rajiv Gandhi Cancer Institute and Research CentreDelhi, National Capital Territory of Delhi, IndiaRecruiting
Rajiv Gandhi Cancer Institute and Research CentreDelhi, National Capital Territory of Delhi, IndiaRecruiting
Rajiv Gandhi Cancer Institute and Research CentreDelhi, National Capital Territory of Delhi, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06712420